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ABSTRACT 
Samantha Tyson Wooten: SECONDARY DATA ANALYSIS OF THE NORTH CAROLINA 
OFFICE OF THE CHIEF MEDICAL EXAMINER’S SUSPECTED POISONING DEATH 
INVESTIGATION EFFORTS   
(Under the direction of Lori Evarts) 
 
Introduction: With a continued increase in North Carolina’s population, an increase in death is 
inevitable. As efforts to increase a community’s health through policies, partnerships, and 
education have grown, the need for robust, multidisciplinary and multicomponent data is 
required to support these interventions. Understanding the investigative processes of one of these 
possible data sources, the North Carolina Office of the Chief Medical Examiner, is essential. 
Objective: Determination of how suspected poisoning deaths are investigated in the state of 
North Carolina. 
Methods: A secondary analysis was conducted using data collected by the local medical 
examiners across the state of North Carolina and the North Carolina Office of the Chief Medical 
Examiner in cases where naloxone was identified in the decedent’s toxicology report from 
October 1, 2017 through May 31, 2018. Qualitative and quantitative data were abstracted and 
analyzed to evaluate the quality of the data collected by the statewide medical examiner system. 
Results: The decedent’s history of receiving medication-assisted treatment was most frequently 
not specified on death investigation reports. Other variables that were not continuously specified 
on death investigation reports included history of diagnosed mental illness, suicide ideation and 
attempt, chronic pain, arrest and/or incarceration, and inpatient or outpatient treatment for 
substance use disorder or mental health treatment. 
Conclusion: The variables identified as important to public health efforts are not consistently 
reported by North Carolina local medical examiners on death investigation reports. It is thus 
highly recommended that the leadership of the North Carolina Office of the Chief Medical 
Examiner revise the current investigation report to encourage established variables to be reported 
during the death investigation process. 
Key Words: Medicolegal data, medical examiner investigations, quality improvement, 
quality assurance, overdose death investigations, poisoning death investigations 
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Introduction
Organizational Background 
United States medical examiner and coroner systems investigate a large portion of deaths 
that occur each year and therefore are a valuable source of information surrounding public health 
interests and preventive medicine (Hanzlick & Parrish, 1996; Bugeja, et. al., 2016). Medical 
examiner systems differ from coroner systems in that there is a governing body and examiners 
are trained physicians or medical professionals that are appointed and trained by the governing 
body (Hanzlick, 2006). In contrast, coroner systems have elected officials performing the 
investigations and autopsies; North Carolina primarily operates on a medical examiner system, 
rather than a coroner system (Hanzlick, 2006). The North Carolina (NC) medical examiner 
system is comprised of state and local partnerships that include the Office of the Chief Medical 
Examiner (OCME), local medical examiners (LME), and regional autopsy facilities (Appendix 
A). The NC OCME oversees the operations of the statewide medical examiner system and 
provides guidance and training to the appointed medical examiners with the goal of ensuring the 
quality of medicolegal death investigations performed. As part of this system, any death that is 
suspected to fall under medical examiner jurisdiction is initially reported to a LME to determine 
whether to accept or decline jurisdiction and what type of postmortem examination is required. 
“The [OCME] investigates all suspicious, violent, unexpected, and sudden deaths in [NC], 
including all suspected drug-related deaths” (Miller, 2016, p.1). During this investigation, 
medical examiners use a Report of Investigation by Medical Examiner (RIME) for all deaths 
(Appendix B) and an additional one that contains questions specific to a suspected poisoning 
(“overdose”) death (Appendix C).  
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Beginning in October 2017, the NC OCME Toxicology Laboratory began testing for the 
presence of naloxone in decedent samples to expand surveillance as part of the Centers for 
Disease Control and Prevention(CDC)-funded Enhanced State Surveillance of Opioid Mortality 
and Morbidity project, also referred to as ESOOS (Centers for Disease Control and Prevention 
[CDC], 2017). This CDC grant was awarded to the North Carolina Department of Health and 
Human Services and currently reports on variables investigated in relation to overdose deaths, 
such as: type of opioid, evidence at scene, naloxone administration, evidence of rapid overdose, 
and decedent history (i.e., arrest, incarceration, mental disorders, and substance use disorder) 
(CDC, 2017). Although this project reports on similar variables collected during investigative 
procedures, the efforts of this project differ in scope and purpose from those relating to the 
ESOOS project.     
With the newly added toxicology testing, the original intent of this paper was to create a 
behavioral analysis of overdose victims to inform public health naloxone distribution efforts 
across North Carolina. Due to the recognition of missing data relating to the variables of interest 
by the study team, this effort changed to focus on the identification of the existing data gaps and 
potential solutions designed to increase the quality of NC OCME data. 
Introduction to the problem 
Kolodny and colleagues wrote that “[I]n 2014, the CDC added opioid overdose prevention to 
its list of top five public health challenges” due to a continuous increase in prescription and illicit 
opioid drug use and abuse (Kolodny, et. al., 2015; CDC, 2014). Across the nation, the opioid 
crisis is affecting all aspects of life for various people that come from a variety of educational 
and socioeconomic backgrounds  (Vadivelu, Kai, Kodumudi, Sramcik, & Kaye, 2018). 
Vulnerable populations have been documented and include former inmates, individuals with 
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psychiatric disorders, and individuals with substance use disorders (Bohnert, et. al., 2012 & 
Ranapurwala, et. al., 2018). Nationally “[b]etween 1999 and 2014, the reported drug overdose 
deaths increased by almost 3-fold” (Vadivelu, et. al., 2018). North Carolina has seen an increase 
in opioid-related overdose deaths and is more than 15% higher than the national rate.  
Specifically, in 2016, there were 1,584 opioid-related deaths in North Carolina—a rate of 15.4 
deaths per 100,000 compared to the national rate of 13.3 deaths per 100,000 persons (Miller, 
2018 & National Institute on Drug Abuse (NIDA), 2018).  
Moreover, the toll that opioid addiction and overdose takes on an individual and family does 
not stop after death occurs. Once death occurs, the investigation into the decedent’s life and 
circumstances surrounding the death begin. This investigation could potentially lead to an 
autopsy, toxicology report, and various other data outputs; all of which will work together to 
inform the pathologist’s cause and manner of death determination. These data act as variables in 
multiple surveillance systems that are then used as evidence to support a number of programs, 
grants, policies, etc. at the local, state, and federal levels. “Public health surveillance provides the 
scientific and factual database essential to informed decision making and appropriate public 
health action” (Nsubuga, et. al., 2006). “Accurately identifying death and its causes is integral to 
the compilation of mortality data and ultimately to the operation of the criminal justice and 
public health systems” therefore, the need for accurate overdose data is crucial for many systems 
(Ruiz, Posey, Neuilly, Stohr, & Hemmens, 2018). Strengthening these data has been deemed 
important to death investigations, criminal justice and public health systems, and furthering 
medical research by the Executive Office of the President’s National Science and Technology 
Council and therefore should also be a concern of the NC OCME (National Science and 
Technology Council, 2016).  
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Objective 
While numerous studies are being conducted using secondary data with the goal of 
studying outcomes and identifying potential solutions to address the opioid crisis, including 
studies focused on naloxone administration and distribution, few studies have examined data 
collection processes and the quality and quantity of primary data. Thus, in order to strengthen the 
quality of primary data sources, a secondary analysis was conducted of local medical examiner 
death investigation data in the state of North Carolina. Local medical examiner death 
investigation data are designed to provide context of the circumstances surrounding a death and 
inform the pathologist’s cause and manner of death determination. This analysis focuses on 
addressing the quantity and quality of variables that are being collected by local medical 
examiners in order to determine which variables needed greater attention during the 
documentation process. 
Methods 
Data used in the analysis were obtained with permission from the NC OCME 
Epidemiologist and were obtained through the NC OCME internal server, the Medical Examiner 
Information System (MEIS). A search query was performed by information technology (IT) 
specialists to identify all cases where the drug naloxone was detected through toxicology testing 
performed by the NC OCME Toxicology Laboratory between October 1, 2017 and May 31, 
2018. The raw data produced by the query contained 515 cases. Once the dataset containing the 
515 cases was received, the NC OCME Epidemiologist reviewed the dataset to ensure that the 
data abstractor was provided de-identified data to maintain the decedent’s anonymity in 
accordance with the submitted University of North Carolina (UNC) Institutional Review Board 
(IRB) application. Before secondary analysis began, the data abstractor and the NC OCME 
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Epidemiologist produced a list of variables that should be captured during NC OCME death 
investigations to facilitate generation of the analysis dataset (Appendix D). These variables were 
identified and defined using the existing NC OCME RIME and were supplemented with 
additional variables of interest as discussed among the data abstractor and the NC OCME 
Epidemiologist. The variables were coded per the Center for Disease Control and Prevention 
(CDC) National Violent Death Reporting System (NVDRS) Coding Manual (CDC, 2015). The 
data abstraction began July 10, 2018 and ended August 10, 2018. Microsoft Excel was used to 
record the data abstracted for each variable. The completed RIMEs for each case were used to 
undertake 100% verification of the data entered into Excel. The analysis dataset was stored on a 
desktop computer with the protection of the NC OCME’s secure computer network. The 
complete Excel spreadsheet was then uploaded to password protected UNC Sakai project 
workspace with access limited to the student and academic adviser. Data analysis was performed 
using Microsoft Excel pivot tables. 
Data Set Description 
The variables included in the raw data resulting from the previously described query 
contained the following information: case folder id, decedent name, birth date, death date, age, 
race, gender, ethnicity, means of death, manner of death, county of death, county of residence, 
autopsy type, toxicology folder id, and drug(s) that were present in decedent’s toxicology report. 
With the exception of folder id, each of these variables were removed before provision to the 
data abstractor to begin abstracting. 
Data were abstracted from the following sources: NC OCME autopsy reports, RIMEs, 
toxicology reports, toxicology cause worksheets, death certificates, supplemental death 
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certificates (if applicable), toxicology request forms, MEIS, and case encounter forms (“case 
calls”). Qualitative and quantitative data were abstracted from each of the 515 identified cases. 
Results 
The findings associated with the sample (n = 515) of decedents whose toxicology testing 
detected naloxone between October 1, 2017 through May 31, 2018 for deaths investigated by 
LMEs and reviewed by the North Carolina Office of the Chief Medical Examiner are described 
below. 
Demographics of Decedent Sample 
Males (57.09%) comprised the majority of the decedent sample, females represented 
33.79%, and 9.13% (n = 47) had a missing gender value due to unavailable case files (7.74%)  or 
gender not being specified during the investigation (0.39%). Ages of the sample ranged from 0 to 
81 years, with an average age of 37.09 and a median age of 35.00 years. Forty-five cases (8.74%) 
lacked information relating to the age of decedent due to an unavailable case file. White 
decedents comprised the majority of the sample (71.65%), followed by Black decedents 
(14.37%), and Native American decedents (1.55%). Sixteen (3.11%) of decedents’ race were 
classified as “other,” 0.58% (n = 3) cases did not report race, and 8.74% of cases (n = 45) had a 
missing race value due to unavailable case files. In regards to ethnicity, 70.68% of decedents (n 
= 364) were identified as “Non-Hispanic,” followed by 3.11% that were identified as “Hispanic”. 
Ethnicity was unknown for a total of 11.65% decedents (n = 60). Of these, 5.83% did not specify 
ethnicity and 8.74% of case files (n = 45) were unavailable. These results are displayed in Table 
1.
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Variable Value 
Gender— no. (%)  
      Male 294 (57.09) 
      Female 174 (33.79) 
      Variable Not Specified 2 (0.39) 
      Case File Unavailable 45 (8.74) 
Age— yr.  
      Mean 37.09 
      Median 35.00 
      Range 0-81 
       <1 6 (1.17) 
      1-4 0 (0) 
      5-9 0 (0) 
      10-14 0 (0) 
      15-19 8 (1.55) 
      20-24 44 (8.54) 
      25-34 163 (31.65) 
      35-44 124 (24.08) 
      45-54 79 (15.34) 
      55-64 41 (7.96) 
      65-74 4 (0.78) 
      75-84 1 (0.19) 
      85+ 0 
      Case File Unavailable 45 (8.74) 
Race—no. (%)  
      Black 74 (14.37) 
      Native American 8 (1.55) 
      White 369 (71.65) 
      Other 16 (3.11) 
      Variable Not Specified 3 (0.58) 
      Case File Unavailable 45 (8.74) 
Ethnicity—no. (%)  
      Non-Hispanic 364 (70.68) 
      Hispanic 16 (3.11) 
      Unknown  60 (11.65) 
      Variable Not Specified 30 (5.83) 
      Case File Unavailable 45 (8.74) 
 
County Information of Decedent Sample 
Decedents in this sample were residents of North Carolina and other states as indicated in 
Table 2. Guilford County (6.41%), Buncombe County (5.44%), Mecklenburg County (5.44%), 
and Wake County (4.85%) had the highest percentages of residence in the decedent sample. 
Fifteen cases (2.91%) involved decedents whose residence was outside of North Carolina, 8.74% 
Table 1. Baseline Characteristics of Decedent Sample (n=515). 
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of cases had missing county value due to unavailable case files, and 0.78% (n = 4) were 
identified as having an “Unknown” county of residence.  
All deaths occurred in the state of North Carolina as indicated in Table 3 with Guilford 
County (10.68%), Mecklenburg County (8.16%), Buncombe County (6.80%), and Wake County 
(5.44%) having the highest percentages of deaths in the decedent sample. The data relating to 
this variable were complete for all cases included in this study.  
 
 
 
 
 
County of Residence—no. 
(%) 
Total 
Alamance 12 (2.33) 
Alexander 4 (0.78) 
Alleghany 1 (0.19) 
Anson 1 (0.19) 
Ashe 2 (0.39) 
Avery 1 (0.19) 
Beaufort 4 (0.78) 
Bertie 1 (0.19) 
Bladen 1 (0.19) 
Brunswick 0 (0) 
Buncombe 28 (4.85) 
Burke 9 (1.75) 
Cabarrus 6 (1.17) 
Caldwell 2 (0.39) 
Camden 1 (0.19) 
Carteret 3 (0.58) 
Caswell 1 (0.19) 
Catawba 4 (0.78) 
Chatham 0 (0) 
Cherokee 1 (0.19) 
Chowan 1 (0.19) 
Clay 1 (0.19) 
Cleveland 2 (0.39) 
Columbus 1 (0.19) 
Craven 6 (1.17) 
Cumberland 22 (4.27) 
Currituck 3 (0.58) 
Dare 4 (0.78) 
Davidson 11 (2.14) 
Davie 2 (0.39) 
Duplin 1 (0.19) 
Durham 4 (0.78) 
Edgecombe 4 (0.78) 
Forsyth 21 (4.08) 
Franklin 4 (0.78) 
Gaston 9 (1.75) 
Gates 0 (0) 
Graham 0 (0) 
Granville 1 (0.19) 
Greene 1 (0.19) 
Guilford 33 (6.41) 
Halifax 3 (0.58) 
Harnett 5 (0.97) 
Haywood 5 (0.97) 
Henderson 11 (2.14) 
Hertford 0 (0) 
Hoke 2 (0.39) 
Hyde 0 (0) 
Iredell 7 (1.36) 
Jackson 2 (0.39) 
Johnston 3 (0.58) 
Jones 1 (0.19) 
Lee 2 (0.39) 
Lenoir 2 (0.39) 
Lincoln 3 (0.58) 
Macon 0 (0) 
Madison 2 (0.39) 
Martin 0 (0) 
McDowell 1 (0.19) 
Mecklenburg 28 (4.85) 
Mitchell 0 (0) 
Montgomery 0 (0) 
Moore 5 (0.97) 
Nash 2 (0.39) 
New Hanover 18 (2.91) 
Northampton 1 (0.19) 
Onslow 4 (0.78) 
Orange 4 (0.78) 
Pamlico 3 (0.58) 
Table 2. County of residence in decedent sample (n=515). 
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Pasquotank 4 (0.78) 
Pender 4 (0.78) 
Perquimans 0 (0) 
Person 1 (0.19) 
Pitt 13 (2.52) 
Polk 1 (0.19) 
Randolph 13 (2.52) 
Richmond 1 (0.19) 
Robeson 8 (1.55) 
Rockingham 5 (0.97) 
Rowan 4 (0.78) 
Rutherford 4 (0.78) 
Sampson 2 (0.39) 
Scotland 4 (0.78) 
Stanly 6 (1.17) 
Stokes 1 (0.19) 
Surry 5 (0.97) 
Swain 2 (0.39) 
Transylvania 1 (0.19) 
Tyrell 0 (0) 
Union 5 (0.97) 
Vance 2 (0.39) 
Wake 25 (10.10) 
Warren 0 (0) 
Washington 0 (0) 
Watauga 0 (0) 
Wayne 4 (0.78) 
Wilkes 7 (1.36) 
Wilson 1 (0.19) 
Yadkin 0 (0) 
Yancey 1 (0.19) 
Case File Unavailable 45 (8.74) 
Out of State 15 (2.91) 
Unknown 4 (0.78) 
 
 
 
 
 
 
County of Death—no. 
(%) 
Total 
Alamance 12 (2.33) 
Alexander 2 (0.39) 
Alleghany 1 (0.19) 
Anson 1 (0.19) 
Ashe 2 (0.39) 
Avery 1 (0.19) 
Beaufort 5 (0.97) 
Bertie 1 (0.19) 
Bladen 1 (0.19) 
Brunswick 1 (0.19) 
Buncombe 35 (6.80) 
Burke 4 (0.78) 
Cabarrus 7 (1.36) 
Caldwell 5 (0.97) 
Camden 0 (0) 
Carteret 5 (0.97) 
Caswell 0 (0) 
Catawba 3 (0.58) 
Chatham 2 (0.39) 
Cherokee 1 (0.19) 
Chowan 1 (0.19) 
Clay 1 (0.19) 
Cleveland 1 (0.19) 
Columbus 1 (0.19) 
Craven 8 (1.55) 
Cumberland 27 (5.24) 
Currituck 2 (0.39) 
Dare 4 (0.78) 
Davidson 8 (1.55) 
Davie 1 (0.19) 
Duplin 1 (0.19) 
Durham 10 (1.94) 
Edgecombe 1 (0.19) 
Forsyth 24 (4.66) 
Franklin 3 (0.59) 
Gaston 11 (2.14) 
Gates 0 (0) 
Graham 0 (0) 
Granville 2 (0.39) 
Greene 0 (0) 
Guilford 55 (10.68) 
Halifax 4 (0.78) 
Harnett 3 (0.59) 
Haywood 6 (1.17) 
Henderson 8 (1.55) 
Hertford 1 (0.19) 
Hoke 2 (0.39) 
Hyde 0 (0) 
Iredell 8 (1.55) 
Jackson 4 (0.78) 
Johnston 3 (0.58) 
Jones 1 (0.19) 
Lee 2 (0.39) 
Lenoir 2 (0.39) 
Lincoln 3 (0.58) 
Macon 0 (0) 
Madison 0 (0) 
Martin 0 (0) 
Table 3. County of death in decedent sample (n=515). 
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McDowell 0 (0) 
Mecklenburg 42 (8.16) 
Mitchell 0 (0) 
Montgomery 0 (0) 
Moore 7 (1.36) 
Nash 6 (1.17) 
New Hanover 26 (5.05) 
Northampton 0 (0) 
Onslow 4 (0.78) 
Orange 6 (1.17) 
Pamlico 2 (0.39) 
Pasquotank 7 (1.36) 
Pender 2 (0.39) 
Perquimans 0 (0) 
Person 1 (0.19) 
Pitt 17 (3.30) 
Polk 1 (0.19) 
Randolph 11 (2.14) 
Richmond 1 (0.19) 
Robeson 5 (0.97) 
Rockingham 4 (0.78) 
Rowan 6 (1.17) 
Rutherford 4 (0.78) 
Sampson 2 (0.39) 
Scotland 4 (0.78) 
Stanly 4 (0.78) 
Stokes 0 (0) 
Surry 6 (1.17) 
Swain 1 (0.19) 
Transylvania 1 (0.19) 
Tyrell 0 (0) 
Union 5 (0.97) 
Vance 4 (0.78) 
Wake 28 (5.44) 
Warren 0 (0) 
Washington 0 (0) 
Watauga 0 (0) 
Wayne 5 (0.97) 
Wilkes 5 (0.97) 
Wilson 1 (0.19) 
Yadkin 0 (0) 
Yancey 0 (0) 
Case File Missing 0 (0) 
Out of State 0 (0) 
Unknown 0 (0) 
History of Diagnosed Mental Illness in Decedent Sample 
The decedent’s history of diagnosed mental illness is displayed in Table 4. As such, 
21.17% of decedents (n = 109) were identified as having a history of diagnosed mental illness. 
Over two-thirds of all 515 cases (68.93%, n = 355) did not specify whether a history of 
diagnosed mental illness was present, while 1.17% of cases had incomplete case files and 8.74% 
(n = 45) were missing data due to unavailable case files at the time of abstraction. 
 
 
History of diagnosed mental 
illness—no. (%) 
Total 
Yes 109 (21.17) 
Variable Not Specified 355 (68.93) 
Incomplete Case File 6 (1.17) 
Case File Unavailable 45 (8.74) 
Total 515 
Table 4. History of diagnoses mental illness in decedent sample (n=515). 
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History of Suicidal Ideation or Suicide Attempt in Decedent Sample 
 As displayed in Table 5, decedents who were identified as having a history of suicidal 
ideation or suicide attempt (SI/SA) account for 5.05% of the decedent sample, whereas 85.05% 
(n = 438) of decedent case files did not specify whether or not the decedent had a history of 
SI/SA. In regards to incomplete and/or unavailable data, 1.17% of cases in the decedent sample 
had incomplete case files and 8.74% of case files were unavailable, resulting in missing data. 
 
 
History of SI/SA—no. (%) Total 
Yes 26 (5.05) 
Variable Not Specified 438 (85.05) 
Incomplete Case File  6 (1.17) 
Case File Unavailable 45 (8.74) 
Total 515 
 
History of Chronic Pain in Decedent Sample 
 History of chronic pain in decedent sample is provided in Table 6. Of which, 9.90% of 
decedents were identified as having a history of chronic pain. Cases where information was not 
specified on whether the decedent had a history of chronic pain accounted for 80.39% of the 
decedent sample (n = 414), while 0.97% (n = 5) had incomplete case files and 8.74% (n = 45) 
had unavailable case files at the time of abstraction, resulting in an absence of data. 
  
Table 5. History of suicidal ideation or suicide attempt in decedent 
sample (n=515). 
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History of Chronic Pain—no. (%) Total 
Yes 51 (9.90) 
Variable Not Specified 414 (80.39) 
Incomplete Case File 5 (0.97) 
Case File Unavailable 45 (8.74) 
Total 515 
 
History of Arrest and/or Incarceration in Decedent Sample 
 As displayed in Table 7, a history of arrest and/or incarceration was identified in 7.96% 
of decedents included in this study. The majority of cases (82.91%, n = 427) did not specify the 
decedent’s arrest and/or incarceration history, 0.39% (n = 2) had incomplete case files, and 
8.74% (n = 45) had no data because the case files were unavailable. 
 
 
History of Arrest and/or 
Incarceration—no. (%) 
Total 
Yes 41 (7.96) 
Variable Not Specified 427 (82.91) 
Incomplete Case File 2 (0.39) 
Case File Unavailable 45 (8.74) 
Total 515 
 
History of Substance Use in Decedent Sample 
 The majority (81.55%, n = 420) of decedents in the sample were identified as having a 
history of substance use and 4.27% were identified as not having a history of substance use as 
Table 7. History of arrest and/or incarceration in decedent sample 
(n=515). 
Table 6. History of chronic pain in decedent sample (n=515). 
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displayed in Table 8. Furthermore, 5.05% of cases in the sample did not specify the decedent’s 
history of substance use, 0.39% (n = 2) had incomplete case files, and 8.74% of cases files were 
unavailable at the time of data abstraction, resulting in missing data.  
 
History of Substance Use—no. (%) Total 
Yes 420 (81.55) 
No 22 (4.27) 
Variable Not Specified 26 (5.05) 
Incomplete Case File 2 (0.39) 
Case File Unavailable 45 (8.74) 
Total 515 
 
History of Treatment in Decedent Sample 
 History of treatment in the decedent sample was assessed, as displayed in Table 9. 
Treatment included inpatient or outpatient (e.g., substance use disorder treatment, mental health 
treatment, etc.). In total, 9.32% (n = 48) of cases included in this study were identified as having 
a history of treatment, while history of treatment of treatment was not specified in 80.78% (n = 
416) of cases, 1.17% (n = 6) had incomplete case files, and 8.74% of cases files were unavailable 
at the time of abstraction. 
 
History of Treatment—no. (%) Total 
Yes 48 (9.32) 
Variable Not Specified 416 (80.78) 
Incomplete Case File 6 (1.17) 
Case File Unavailable 45 (8.74) 
Total 515 
Table 9. History of treatment in decedent sample (n=515). 
Table 8. History of substance use in decedent sample (n=515). 
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History of Medication-Assisted Treatment in Decedent Sample  
The decedent’s history of medication-assisted treatment (MAT), including treatment with 
buprenorphine, methadone, or naltrexone, was assessed. While 4.66% (n = 24) of cases included 
in this study were identified as having a history of MAT, this variable was not specified in the 
majority (85.44%, n = 440) of cases. Incomplete case files and unavailable case files resulted in 
missing data for 1.17% (n = 6) and 8.74% (n = 45) cases, respectively. These results are 
displayed in Table 10. 
 
 
History of MAT—no. (%) Total 
Yes 24 (4.66) 
Variable Not Specified 440 (85.44) 
Incomplete Case File 6 (1.17) 
Case File Unavailable 45 (8.74) 
Total 515 
 
Discussion 
 
 In Tables 1 through 10, 45 case files were unavailable during the month-long data 
abstraction and therefore did not have data reported for the variables of interest. This lack of 
availability can be attributed to the varying length of time that it can require to finalize cases in 
comparison to when the search query and abstraction process began. The NC OCME’s ability to 
finalize cases depends on a variety of factors such as staffing and resource limitations, current 
and past caseload, ability to obtain investigative information from law enforcement and other 
sources, turnaround times associated with toxicology testing, complexity of the specific case, 
Table 10. History of medication-assisted treatment in decedent sample (n=515). 
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etc.). The National Association of Medical Examiners (NAME) provides a list of standards that 
an office should follow in order to be accredited provisionally or fully, including the number of 
days a case must be completed. For full accreditation, NAME suggests that “90% of reports of 
all postmortem examinations [are] completed within 60 calendar days from the time of autopsy” 
and for provisionally accredited offices it is suggested that “90% of reports of all postmortem 
examinations [are] completed within 90 calendar days from the time of autopsy” (National 
Association of Medical Examiner [NAME], 2014). NAME accreditation represents an 
independent verification that the minimum standards associated with performing medicolegal 
death investigations are being fulfilled, thus assuring the quality of the work performed and 
promoting the standardization of practices in the United States. Although the NC OCME has not 
yet received NAME accreditation, it is committed to performing high-quality medicolegal death 
investigations to promote the health, safety, and well-being of all North Carolinians. This 
commitment has been demonstrated through an award from the National Institute of Justice, 
which will provide $700,000 in funding to support the expansion of the NC OCME 
Investigations Unit and the standardization of medicolegal death investigations in North 
Carolina.  
There were 60 cases that were identified as having “Unknown” listed for ethnicity. As the 
sole data abstractor in this effort, it was evident through the abstraction process that some LMEs 
are consistently providing more information and extensive narratives than others. It is through 
observations during the abstraction process that these missing values may have been due to a 
lack of resources available to the LME to complete their investigations.   
Rates per 100,000 were not calculated because 88.00% of the reported counties for the 
variable “County of Residence” and 91.00% of reported counties for the variable “County of 
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Death” had less than 10 deaths in this sample (Tables 2 and 3). Through observations during 
abstraction, cases that were identified as having an “Unknown” county of residence are again 
likely due to lack of resources the LME used or had available to complete their investigation. 
The variables displayed in Tables 4, 5, and 7 including “History of diagnosed mental 
illness,” “History of suicidal ideation or suicide attempt,” and “History of arrest and/or 
incarceration,” respectively,  are not currently required fields on the RIME. As a result, the 
number of cases with missing data are expected to be increased. Table 6 displays “History of 
chronic pain,” which is currently a field on the required RIME, but this sample was found to 
contain a high percentage (80.39%) of cases (n = 417) that did not specify whether or not the 
decedent had a history of chronic pain. Through observations during the abstraction processes, 
this may have been due to a combination of factors that include LMEs not fully completing the 
fields included on the RIME and/or a lack of resources available to the LME during their 
investigation. 
Limitations 
One of the limitations of this paper is that further interviews were not conducted to 
identify the sources of potentially inadequate investigation processes from a systematic 
viewpoint or individual LMEs’ viewpoint. Further information should be obtained to understand 
how to better support the local medical examiners throughout their investigative processes. This 
information would provide context to the leadership team to establish quality improvement and 
assurance methods with the goal of creating a more detailed and robust gathering and entering of 
medicolegal data. 
A second limitation of this paper is that the data obtained and abstracted were limited to 
only cases where naloxone was present in the toxicology report and within a seven-month time 
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period, resulting in only 515 cases. By expanding the study to include all poisoning deaths, not 
solely cases where naloxone was tested for and detected, the study would yield a dataset 
containing a more accurate depiction of the data that the NC OCME can provide and trends 
concerning the accuracy and depth of the data. Evaluation of this information would inform 
efforts to reduce the impact of addiction and overdose in NC.  
A third limitation of this paper is the compressed data abstraction process occurring over 
a period of one month. It was found that 45 cases files were unavailable during the data 
abstraction time period and therefore incomplete data available to report. Since NC OCME’s 
goal to accurately determine the cause and manner of death in each case is based on complex 
factors including information collected and provided by internal and external sources, it is 
recognized by the research team that not all cases were able to be resolved before the abstraction 
process began. Therefore, expanding the time period for the data abstraction processes, focusing 
on cases from the previous year, might allow for a greater proportion of cases included in the 
sample to be evaluated. 
A final limitation of this paper is the lack of comparative analyses of other medical 
examiner and coroner systems. Due to the lack of uniformity and lack of available information 
for the various medical examiner/coroner systems across the country, comparisons between 
states is difficult. The development and implementation of a national database would improve 
the communication and uniformity of national medical examiner/coroner systems and allow for 
additional quality improvement methods through comparative analyses. This proposed database 
would also be used to promote the standardization of practices and communication of critical 
data points collected by medical examiner/coroner systems in the United States.  
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Recommendations 
Medical examiner data represent a valuable resource for various systems and to assess 
public health problems across the nation. It is important for LMEs to collect and report robust, 
multidisciplinary, and multicomponent data. While the data collected and reported by LMEs 
provide valuable insight into the circumstances surrounding suspected poisoning deaths in North 
Carolina, it was found that many death investigation reports did not specify variables of interest 
to the study team. As these variables of interest may be useful in assessing and addressing the 
opioid crisis, it is my recommendation that the NC OCME leadership team (a) revise the current 
suspected poisoning portion of the RIME to expand the required variables that LMEs are to ask 
and document during their investigations, (b) update the demographics portion of the RIME to 
adhere to national standards, and (c) for the NC OCME to develop additional training materials 
and expand existing training efforts to educate and motivate current and future LMEs on the 
need to use this revised RIME. It is also important to acknowledge that the NC OCME’s ability 
to implement the recommendations outlined in this paper is dependent upon the availability of 
staffing and resources provided by the state of North Carolina.          
Revision of the Report of Investigation by Medical Examiner 
 It is recommended to expand the current RIME to include variables that will aid in 
addressing public health concerns in vulnerable populations and inform the expansion of public 
health interventions. Variables that should be added to the current RIME include: history of 
diagnosed mental illness, history of suicidal ideation or suicide attempt, history of arrest and/or 
incarceration, history of treatment, and history of MAT. Individuals with a history of arrest 
and/or incarceration, suicidal ideation or suicide attempt, and/or diagnosed mental illness are 
vulnerable to substance use disorders, including opioid use disorder and overdose (Bohnert, et. 
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al., 2012 & Ranapurwala, et. al., 2018). Therefore, these variables should be accurately gathered 
and analyzed in order to provide evidence in support of expanded public health resources and 
relevant interventions. The collection of data on history of treatment and specifically, history of 
MAT, could potentially provide evidence to expand access to evidence-based treatment across 
the state if data indicate a relatively low number of individuals receiving various forms of 
treatment. According to the Substance Abuse and Mental Health Services Administration 
(SAMHSA), improving access to and quality of treatment for individuals with Opioid Use 
Disorder (OUD) is necessary “given the strong evidence of effectiveness for such treatments” 
(Substance Abuse and Mental Health Services Administration [SAMHSA], 2018).  
Currently, the RIME includes variables deemed important to addressing the opioid crisis 
such as history of chronic pain, prescription drug misuse or previous overdose, and medical 
history. However, as displayed in Table 4 and Table 6, there is a significant percentage of 
information not continuously or reliably specified on the RIME. Specifically, in the decedent 
sample (Table 6) 80.39% of cases did not specify whether or not the decedent had a history of 
chronic pain. By expanding the documentation of key variables of interest, the LME may provide 
useful information for various systems, policies, and interventions. 
Additionally, during the abstraction process, it was noted that the RIME and MEIS both 
report race for American Indian decedents as “Native American” and as such, LMEs report 
identically. However, death certificates, a standardized document, report this specific race as 
“American Indian or Alaska Native” (CDC, 2003). It is my recommendation that the NC OCME 
leadership team update the reporting of race to conform with national standards. 
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Training Sessions 
In addition to expanding the variables that are required to be asked and documented 
during a death investigation, it is recommended that a required training session for all current and 
future LMEs should be added. The goal of the training is to educate and motivate LMEs on the 
need to use and complete this revised RIME to collect the recommended data to address 
communities where specific deaths have occurred. From a leadership standpoint, “two ways to 
tackle [limited high output is] through training and motivation” (Grove, 1995, p. 158).  
The motivational goal of this training should be based on Maslow’s hierarchy of needs 
which states that needs drive motivation: highlighting the need for payment of work done, 
security of a job, implementation of a recognition program, and tying together the importance of 
this data to the external customers, and society as a whole, that rely on its quality (Grove, 1995 
& Maslow, 1943). By focusing on an adaptive change rather than the incremental change of a 
RIME, the overall performance is believed to increase in quality (Heifetz, Grashow, & Linsky, 
2009).  
Currently, the NC OCME monitors and evaluates the performance of the appointed 
medical examiners through established quality assurance processes. It is proposed that 
incomplete reports should be considered in the context of an appointed medical examiner’s 
overall performance when providing guidance and directing training efforts. 
Proposed Framework for Change 
 Appendix E displays a proposed framework for change by using a logic model. This 
framework operates under the assumption that the leadership team has already approved this 
change and has allocated funds to achieve this change. This proposed framework suggests 
engagement with stakeholders, feedback from stakeholders, a pilot program to assess 
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acceptability and feasibility, and full implementation in all 100 counties after five years.  The 
overall impact goal of less than 10% of variables collected being identified as “Variable Not 
Specified,” on average. This would result in a reduction from the current average value of 
approximately 70% of cases in the identified sample. 
Evaluation Methods 
 Evaluation of this change process between pilot testing and full implementation at five 
years is suggested to occur in stages of change, displayed through a timeline in Appendix F. This 
timeline proposes one year of piloting the changes, a reduction at year two to 60% or less of 
variables being collected identified as “Variable Not Specified,” 20% or less at year three; which 
includes 50% of counties at full implementation, and a final goal of less than 10% at year five 
including 100% of counties at full implementation. These metrics will be measured by 
performing bi-annual research reports similar to this effort. 
Sustainability Plan 
In order to maintain buy-in and acceptance of this change from LMEs after full 
implementation at five years, it is suggested that a recognition program be implemented. This 
recognition program will generate quarterly report charts to indicate the percentage completion 
of the RIMEs as completed by LMEs. Once these quarterly charts are produced, they should be 
shared across the NC OCME leadership team and all NC LMEs to highlight the excellent work 
by those who are fully completing the RIME. 
Conclusion 
 In conclusion, as the data abstractor, I am hopeful that the NC OCME leadership team 
will adapt these proposed recommendations for the investigative processes of the NC medical 
examiner system, in combination with the suggested training sessions. I am also hopeful that the 
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state of North Carolina will support the NC OCME’s efforts to standardize medicolegal death 
investigations across the state through increased funding. In addition, I am optimistic that the 
LMEs will take this proposed opportunity to further their education and investigative practices. 
Furthermore, I believe this proposed change process is a great opportunity to enhance the data 
that the NC OCME can provide to various entities across the state and nation to inform public 
health interventions and policy decisions.  
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APPENDIX A: HIGH-LEVEL SUMMARY OF THE MEDICAL EXAMINER CASE 
FLOW 
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APPENDIX B: CURRENT REPORT OF INVESTIGATION BY MEDICAL EXAMINER 
 
 
North Carolina Office of the Chief Medical Examiner                 Investigation Worksheet 
 
Date:______________  Time: ___________ Notified by:_________________________________________ County: _____________________ 
 
Phone number of caller:_________________________________   Local ME  or Caller’s Agency:____________________________________ 
 
 
Decedent Demographics:   Decedent: ___________________________________________________________________________________    
 
Date of Birth: ________________________________   Age: ____________ Race: _______________________ Sex:    Male      Female       Unk 
 
Residence: _______________________________________________________________________________ Zip:_______________________   
Identified?   No    Yes, by:__________________  Relationship:    LE    Spouse/ Sig Other   Child   Parent   Friend   Other: _________ 
Means?   Visual    Driver’s license/ State ID     Photo     Fingerprint    Circumstantial 
If tentative or circumstantial ID, how is positive ID going to be made?    Dentals    Imaging  (please send w/ decedent )     Fingerprints 
Facility where imaging/ dentals are (name and number): ____________________________________________________________________ 
Next of Kin Information:  Has the next of kin been notified?  Yes   No 
Name:____________________________________________Relationship:_________________Phone number:_________________________ 
 
Circumstances of Death: 
Last Known Alive: _________________Time: _____________ By: ____________ Condition/ Activity/ Behavior:________________________ 
Date Found: _____________________ Time: _____________ By: ____________ 911 time:________________________ 
Date Pronounced: _______________________   Time: _____________  By:   Doctor      EMS    Police     Other:________ 
Approximate weight:________lbs,   Approximate height:_______ft _______in 
Any trauma noted on decedent?   No   Yes, describe: _____________________________________________________________________ 
Any recent falls, injuries, or trauma?  No   Yes, explain: ___________________________________________________________________ 
Any recent complaints of illness or injury?  No   Yes, explain: _______________________________________________________________ 
Alcoholism:  No   Yes:   current    quit ______yrs             Tobacco use:   No    Yes:   current    quit   
Illicit or RX drug abuse (If yes, specify which drug used):   No    Yes: __________________________________________________________ 
History of RX overuse or previous overdoses?   No    Yes (year and med): _____________________________________________________ 
Foul play suspected?   No   Yes, specify: ________________________________________________________________________________ 
Abuse or neglect allegations/issues No   Yes, explain: _____________________________________________________________________ 
*For any non-natural incident, please review the Non-Natural Incident Reference Form for the Investigative Worksheet. * 
Place of Death:         
ATTENDED DEATHS: 
  Hospital death:   Name of Facility: ____________________________________________ Date of Admit or time of ER arrival:___________ 
       DOA     ER     Inpatient    Medical Record #:_________________Admit/Trauma Name (if different) ___________________________ 
If admit through ER, what was the mode of arrival:   EMS   Private vehicle   Other:______________________________________  
Where was dec brought in from?    Res    Street   Motel/ Hotel   Other:________ Address: ______________________________ 
If Direct admit, from what facility: _____________________________________ Date of arrival at original facility:_______________ 
Recent surgery? Type: ___________________________________________________________________Date: _________________ 
Tox results: __________________________ Imaging results: _________________________________________________________ 
Is admission blood available?    No   Yes (If yes, please send admission blood and medical records with the body)  
 
  Nursing Home/ Hospice Death:    Facility name: ________________________ Address: ______________________________________ 
 
  Federal Medical Center  /   Central Prison Hospital Death 
 
UNATTENDED DEATHS: 
  Scene Death:           Residence    Motel/ Hotel    Street/ Highway     Jail/Prison (see questions below)    Other: __________________ 
Address where Pronounced: (if different than residence) ____________________________________________________________ 
Decedent’s position found:   Supine    Prone    Lateral  R / L  Other: __________ Location w/in scene:___________________ 
Clothed:   No   Yes, specify: _____________________________Were the clothes on appropriately:   No   Yes, specify: _______ 
Was residence locked/secured?  Yes   No         ETOH found on scene?    No   Yes: __________________________________ 
Illicit drugs or paraphernalia found on scene?   No   Yes, specify: ____________________________________________________ 
  Jail/ Prison: Facility Name: __________________________________________________________________________________________ 
Where in the facility was the decedent found unresponsive (Unit)? ____________________________________________________ 
Where within that unit was the decedent found (i.e.: cell, shower, common area)? ________________________________________ 
Specific location within prison the decedent was actually pronounced? _________________________________________________ 
Was the decedent in a cell alone? _______________________________________________________________________________ 
Was decedent accessible to other inmates between LKA time they were found unresponsive?   Yes   No 
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APPENDIX B: CURRENT REPORT OF INVESTIGATION BY MEDICAL EXAMINER 
(CONTINUED) 
 
 
Medical History:   None  Unknown to caller     Yes, specify:    HTN     CAD     HLD    DM    COPD    CVA    Cirrhosis     Dementia    
 Chronic pain (do med log w/pain med counts)   Other: ___________________________________________________________________ 
 Seizures (Reference Form for the Investigative Worksheet):   TBI  Non-TBI:__________________________ Other: _________________ 
 Paraplegic/Quadriplegic:  No   Yes, Cause:_____________________________Complications:___________________________________ 
Medications on scene - List for non-controlled medications: _________________________________________________________________ 
__________________________________________________________________________________________________________________ 
Controlled substance inventory:  
Date Filled/ 
Prescribed 
Medication Dose Instructions Doctor Amount 
Prescribed 
Amount 
Left 
       
       
       
       
       
       
       
       
       
 
Doctor or Facility treated at: ____________________________________________________________Phone Number:__________________ 
 
Law Enforcement:  Agency: __________________________ Officer: ______________________________ Phone: __________________ 
Will law enforcement be at autopsy?    Yes     No    Unknown by caller 
Date and time told to be at OCME: ___________________________________ 
__________________________________________________________________________________________________________________ 
NOTES: 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Exam:  Aut  Ext   ID only  Doc only  Non-ME      
Date to arrive:________Transporter:_________ 
  OCME    LoME   Other: ________________ 
  Consulted Pathologist:__________________ 
PRELIM CAUSE OF DEATH:_________________ 
PRELIM MANNER OF DEATH:   N  A  H  S  P 
Call Taker:______________________________ 
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APPENDIX C: CURRENT NON-NATURAL REPORT OF INVESTIGATION BY 
MEDICAL EXAMINER (INCLUDING POISONING DEATHS) 
 
 
 Was one decedent dependent upon the other for 24-hour care? 
 Are there different levels of decomposition between the two decedents? 
Does it appear that the caretaker died then the decedent that needed the care died because they couldn’t care for themselves? 
 
MVC:   
What type of vehicles (ie: car, pickup, semi-truck, motorcycle, etc.) were involved? 
Motorcycle: 
 Was the decedent wearing a helmet?  
Was the helmet DOT approved?  
Were they wearing any other protective gear? 
Number of vehicles involved 
Was the decedent the driver, passenger, or occupant of the vehicle? 
If the decedent was the driver, were they an experienced driver or motorcycle operator? 
Was the decedent restrained? 
Air bags deployed? 
Was there significant damage to the vehicle?   
 How much documented intrusion into the passenger compartment? 
Position of decedent within vehicle when found 
Position of decedent, if ejected 
Hit and Run? 
If hit and run, has vehicle been found?   
If decedent was pedestrian:   
Was the decedent wearing dark clothing?  
Was the decedent crossing at a cross walk? 
Was the decedent thought to be under the influence of etoh/drugs? 
Any obstruction, construction, or adverse weather? 
Lighting in the area of the incident? 
Posted speed limit in area and approximate speed the vehicle was thought to be traveling 
Was ETOH or drugs thought to be involved? 
Any charges pending or will be pending? 
Brief description of crash
Non-ME Cases:  
Was the physician notified to sign the death certificate? If yes, please indicate the doctor’s name and phone number? 
Did they agree to sign the dc? If no, please indicate the reason given. 
 It is requested that the ME actually contact the physician themselves to give the circumstances of the death and discuss the case  
  with the physician of record, if there is an issue.  Also, the physician can call OCME during business hours for circumstances of   
  death and advice on how to sign the DC. 
 
Poisoning Allegations: 
Any person that calls with allegations of poisoning, must contact the law enforcement in the city/county where they suspect the 
poisoning occurred and report their suspicions to them. 
Find out where the decedent is and place a call to have the body held until OCME makes a decision about exam status. 
OCME must have an idea of what may have been used to poison the decedent. 
 What was the suspect’s occupation? 
 What was accessible for poisoning? 
 Cleaners/ poisons in the house? 
 Medications? 
 OCME will need a list from LE of name brands and ingredients of items that may have been used in the poisoning for tox. 
 Tox can’t do a “BLANKET” tox for everything. We must have a clue what could have been used. 
Call/ Consult a pathologist for guidance with all this information after you receive the first call. 
Seizure history:   
Etiology:  
TBI, list trauma that caused 
Natural 
Other (specify) 
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APPENDIX D: ABSTRACTION VARIABLES 
 
 
 
 
 
Variable Code Description 
Identifying Number 1-515 Used to protect decedent's identity 
Date of Birth dd/mm/yyyy Source: death certificate, supplemental death certificate 
Date of Death dd/mm/yyyy Source: death certificate, supplemental death certificate 
Age 0-XXX (years) Source: death certificate, supplemental death certificate 
Race 
Asian 
Source: investigation report 
Black 
Native American 
White 
Other 
Unknown 
Ethnicity 
Hispanic 
Source: investigation report Non-Hispanic 
Unknown 
Gender 
Female 
Source: investigation report; specify transgender, if mentioned Male 
Unknown 
County of Residence XXXX Source: death certificate; specify county in NC → if outside NC, specify state 
County of Death XXXX Source: death certificate; specify county in NC → if outside NC, specify state 
Cause of Death (AR) 
Literal text 
Source: autopsy report; “N/A” if an autopsy wasn’t performed 
N/A  
Cause of Death (DC) Literal text Source: death certificate or supplemental death certificate 
Examination Type 
Autopsy 
Source: Medical Examiner Information System (MEIS) External 
Private Autopsy 
Body Condition 
Intact 
Source: autopsy report 
Decomposed 
Embalmed 
Unspecified 
Height Height (inches) Source: autopsy report 
Weight Weight (pounds) Source: autopsy report 
Manner of Death 
Accident 
Source: death certificate, supplemental death certificate 
Homicide 
Natural 
Pending 
Suicide 
Undetermined 
Means of Death 
Abuse or Neglect 
Source: Medical Examiner Information System (MEIS) 
Animals 
Asphyxia 
Blunt 
Drowning 
Electrocution 
Environmental 
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APPENDIX D: ABSTRACTION VARIABLES (CONTINUED) 
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APPENDIX D: ABSTRACTION VARIABLES (CONTINUED) 
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APPENDIX E: PROPOSED FRAMEWORK FOR CHANGE LOGIC MODEL 
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APPENDIX F: PROPOSED TIMELINE 
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